financetom
Business
financetom
/
Business
/
Southern Missouri Bancorp Insider Sold Shares Worth $563,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Southern Missouri Bancorp Insider Sold Shares Worth $563,000, According to a Recent SEC Filing
Jul 29, 2025 3:19 PM

05:38 PM EDT, 07/29/2025 (MT Newswires) -- William E Young, Director, on July 28, 2025, sold 10,000 shares in Southern Missouri Bancorp ( SMBC ) for $563,000. Following the Form 4 filing with the SEC, Young has control over a total of 102,356 common shares of the company, with 1,400 shares held directly and 100,956 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/916907/000141588925020481/xslF345X05/form4-07292025_090736.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ryman Hospitality Properties Insider Bought Shares Worth $789,769, According to a Recent SEC Filing
Ryman Hospitality Properties Insider Bought Shares Worth $789,769, According to a Recent SEC Filing
Aug 7, 2024
11:37 AM EDT, 08/07/2024 (MT Newswires) -- Colin V Reed, Director, Executive Chairman of the Board, on August 06, 2024, executed a purchase for 8,077 shares in Ryman Hospitality Properties ( RHP ) for $789,769. Following the Form 4 filing with the SEC, Reed has control over a total of 1,400,509 shares of the company, with 827,220 shares held directly...
Takeda Wins European Commission's Approval for Adzynma to Treat Blood Clotting Disorder
Takeda Wins European Commission's Approval for Adzynma to Treat Blood Clotting Disorder
Aug 7, 2024
11:45 AM EDT, 08/07/2024 (MT Newswires) -- Takeda Pharmaceutical ( TAK ) said Wednesday it received approval from the European Commission for Adzynma for the treatment of congenital thrombotic thrombocytopenic purpura, a rare blood clotting disorder caused by a deficiency in the ADAMTS13 enzyme. Takeda said the EC approval does not have any impact on its consolidated forecast for the...
Update: KITS Eyecare Up 3.4% as It Swings to Q2 Profit as Revenue Hits a Record High
Update: KITS Eyecare Up 3.4% as It Swings to Q2 Profit as Revenue Hits a Record High
Aug 7, 2024
11:45 AM EDT, 08/07/2024 (MT Newswires) -- KITS Eyecare ( KTYCF ) on Wednesday said it swung to a profit in the second-quarter as revenue jumped 26% to a record. The on-line eyeglasses company said its second-quarter came in at $187,000, or $0.01 per share, swinging from a loss of $1.2 million, or $0.04, in the year-prior period. Revenue rose...
Caterpillar Demonstrates Quality Attributes, Resilience Amid Macro Slowdown, BofA Says
Caterpillar Demonstrates Quality Attributes, Resilience Amid Macro Slowdown, BofA Says
Aug 7, 2024
11:42 AM EDT, 08/07/2024 (MT Newswires) -- Caterpillar ( CAT ) demonstrated some quality attributes relative to other original equipment manufacturers with growth in adjusted operating profit amid a decline in sales, margin expansion despite destocking and negative dealer retailer sales, and pricing over cost, BofA Securities said in a note Wednesday. The firm said it still expects risks of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved